Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells

Journal of Cellular Physiology

Volumn 184, Issue 2, 2000, Pages 263-274

  Wang, Exing ^a   Lee, Michele D ^a   Dunn, Kenneth W ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; DOXORUBICIN;

ARTICLE; CANCER CELL CULTURE; CELL TRANSFORMATION; CELL VACUOLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DETERMINATION; ENDOSOME; FEMALE; HUMAN; HUMAN CELL; LYSOSOME; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; UTERUS SARCOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; DAUNORUBICIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; LYSOSOMES; SARCOMA; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0033921304     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4652(200008)184:2<263::AID-JCP15>3.0.CO;2-F     Document Type: Article

References (71)

1. Altan N, Chen Y, Schindler M, Simon SM. 1998. Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 187:1583-1598.
2. Bae HR, Verkman AS. 1990. Protein kinase A regulates chloride conductance in endocytic vesicles from proximal tubule. Nature 348: 637-639.
3. Barasch J, Gershon MD, Nunez EA, Tamir H, al-Awqati Q. 1988. Thyrotropin induces the acidification of the secretory granules of parafollicular cells by increasing the chloride conductance of the granular membrane. J Cell Biol 107:2137-2147.
4. Beck WT. 1987. The cell biology of multiple drug resistance. Biochem Pharmacol 36:2879-2887.
5. Boscoboinik D, Gupta RS, Epand RM. 1990. Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian cells. Br J Cancer 61:568-572.
6. Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA, Kruh GD. 1995. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 55:5342-5347.
7. Chen G, Duran GE, Steger KA, Lacayo NJ, Jaffrezou JP, Dumontet C, Sikic BI. 1997. Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J Biol Chem 272:5974-5982.
8. Cleary I, Doherty G, Moran E, Clynes M. 1997. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem Pharmacol 53: 1493-1502.
9. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line [see comments]. Science 258:1650-1654.
10. de Lange JH, Schipper NW, Schuurhuis GJ, ten Kate TK, van Heijningen TH, Pinedo HM, Lankelma J, Baak JP. 1992. Quantification by laser scan microscopy of intracellular doxorubicin distribution. Cytometry 13:571-576.
11. Dumontet C, Bodinf, Michal y. 1998. Potential interactions between antitubulin agents and temperature: implications for modulation of multidrug resistance. Clin Cancer Res 4:1563-1566.
12. Dunn K, Maxfield FR. 1998. Ratio imaging instrumentation. Methods Cell Biol 56:217-236.
13. Dunn KW, Mayor S, Myers JN, Maxfield FR. 1994a. Applications of ratio fluorescence microscopy in the study of cell physiology. FASEB J 8:573-582.
14. Dunn KW, McGraw TE, Maxfield FR. 1989. Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome. J Cell Biol 109:3303-3314.
15. Dunn KW, Park J, Semrad CE, Gelman DL, Shevell T, McGraw TE. 1994b. Regulation of endocytic trafficking and acidification are independent of the cystic fibrosis transmembrane regulator. J Biol Chem 269:5336-5345.
16. Endicott JA, Ling V. 1989. The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann Rev Biochem 58:137-171.
17. Fuchs R, Male P, Mellman I. 1989. Acidification and ion permeabilities of highly purified rat liver endosomes. J Biol Chem 264:2212-2220.
18. Futter CE, Gibson A, Allchin EH, Maxwell S, Ruddock LJ, Odorizzi G, Domingo D, Trowbridge IS, Hopkins CS. 1998. In polarized MDCK cells basolateral vesicles arise from clathrin-gamma-adaptin-coated domains on endosomal tubules. J Cell Biol 141:611-623.
19. Gervasoni Jr JE, Fields SZ, Krishna S, Baker MA, Rosado M, Thuraisamy K, Hindenburg AA, Taub RN. 1991. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res 51:4955-4963.
20. Gosland M, Tsuboi C, Hoffman T, Goodin S, Vore M. 1993. 17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter. Cancer Res 53:5382-5385.
21. Gosland MP., Gillespie MN, Tsuboi CP, Tofiq S, Olson JW, Crooks PA, Aziz SM. 1996. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine. Cancer Chemother Pharmacol 37:593-600.
22. Gosland MP, Lum BL, Sikic BI. 1989. Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells. Cancer Res 49:6901-6905.
23. Gottesman MM, Pastan I. 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 62:385-427.
24. Harker WG, Bauer D, Etiz BB, Newman RA, Sikic BI. 1986. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Cancer Res 46:2369-2373.
25. Harker WG, MacKintosh FR, Sikic BI. 1983. Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs. Cancer Res 43:4943-4950.
26. Harker WG, Sikic BI. 1985. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Cancer Res 45:4091-4096.
27. Hoffman MM, Wei LY, Roepe PD. 1996. Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance? J General Physiol 108:295-313.
28. Hurwitz SJ, Terashima M, Mizunuma N, Slapak CA. 1997. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes. Blood 89:3745-3754.
29. Johnson LS, Dunn KW, Pytowski B, McGraw TE. 1993. Endosome acidification and receptor trafficking: bafilomycin A1 slows receptor externalization by a mechanism involving the receptor's internalization motif. Mol Biol Cell 4:1251-1266.
30. Keizer HG, Joenje H. 1989. Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil. J Natl Cancer Inst 81:706-709.
31. Kim H, Barroso M, Samanta R, Greenberger L, Sztul E. 1997. Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells. Am J Physiol 273:C687-C702
32. Klohs WD, Steinkampf RW. 1988. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells. Molecular Pharmacology 34:180-185.
33. Lau DH, Duran GE, Lewis AD, Sikic BI. 1994. Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker. Br J Cancer 70:79-84.
34. Lautier D, Bailly JD, Demur C, Herbert JM, Bousquet C, Laurent G. 1997. Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells. Int J Cancer 71:292-299.
35. Lelong IH, Guzikowski AP, Haugland RP, Pastan I, Gottesman MM, Willingham MC. 1991. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter. Mol Pharmacol 40: 490-494.
36. Luckie DB, Krouse ME, Law TC, Sikic BI, Wine JJ. 1996. Doxorubicin selection for MDR1/P-glycoprotein reduces swelling-activated K+ and Cl-currents in MES-SA cells. Am J Physiol 270:C1029-C1036
37. Luz JG, Wei LY, Basu S, Roepe PD. 1994. Transfection of mu MDR 1 inhibits Na(+)-independent C1-/-HCO3 exchange in Chinese hamster ovary cells. Biochemistry 33:7239-7249.
38. Ma L, Center MS. 1992. The gene encoding vacuolar H(+)-ATPase subunit C is overexpressed in multidrug-resistant HL60 cells. Biochem Biophys Res Commun 182:675-681.
39. Marquardt D, Center MS. 1991. Involvement of vacuolar H(+)-adenosine triphosphatase activity in multidrug resistance in HL60 cells. J Natl Cancer Inst 83:1098-1102.
40. Maxfield FR, Dunn K. 1990. Studies of endocytosis using image identification fluorescence microscopy and digital image analysis. In: Herman B, Jacobson K, editors. Optical Microscopy for Biology. Wiley-Liss, Inc., 357-371.
41. Millot C, Millot JM, Morjani H, Desplaces A, Manfait M. 1997. Characterization of acidic vesicles in multidrug-resistant and sensitive cancer cells by acridine orange staining and confocal microspectrofluorometry. J Histochem Cytochem 45:1255-1264.
42. Moriyama Y, Manabe T, Yoshimori T, Tashiro Y, M Futai. 1994. ATP-dependent uptake of anti-neoplastic agents by acidic organelles. J Biochem 115:213-218.
43. Ohkuma S, Poole B. 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci USA 75:3327-3331.
44. Presley JF, Mayor S, Dunn KW, Johnson LS, McGraw TE, Maxfield FR. 1993. The End2 mutation in CHO cells slows the exit of transferrin receptors from the recycling compartment but bulk membrane recycling is unaffected. J Cell Biol 122:1231-1241.
45. Presley JF, Mayor S, McGraw TE, Dunn KW, Maxfield FR. 1997. Bafilomycin A1 treatment retards transferrin receptor recycling more than bulk membrane recycling. J Biol Chem 272:13929-13936.
46. Roepe PD. 1992. Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry 31:12555-12564.
47. Ruetz S, Gros P. 1994. A mechanism for P-glycoprotein action in multidrug resistance: are we there yet? Trends Pharmacol Sci 15: 260-263.
48. Rutherford AV, Willingham MC. 1993. Ultrastructural localization of daunomycin in multidrug-resistant cultured cells with modulation of the multidrug transporter. J Histochem Cytochem 41:1573-1577.
49. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen TH, van Kalken CK, Slovak ML, de Vries EG, van der Valk P. 1993. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 53: 1475-1479.
50. Schindler M, Grabski S, Hoff E, Simon SM. 1996. Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr). Biochemistry 35:2811-2817.
51. Sehested M, Skovsgaard T, van Deurs B, Winther-Nielsen H. 1987a. Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines. J Natl Cancer Inst 78:171-179.
52. Sehested M, Skovsgaard T, van Deurs B, Winther-Nielsen H. 1987b. Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil. Br J Cancer 56:747-751.
53. Seidel A, Hasmann M, Loser R, Bunge A, Schaefer B, Herzig I, Steidtmann K, Dietel M. 1995. Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multi-drug-resistant gastric carcinoma EPG85-257 cells. Virchows Archiv 426:249-256.
54. Shapiro AB, Fox K, Lee P, YD Yang, Ling V. 1998. Functional intracellular P-glycoprotein. Int J Cancer 76:857-864.
55. Simon S, Roy D, Schindler M. 1994. Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci USA 91:1128-1132.
56. Simon SM, Schindler M. 1994. Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 91:3497-3504.
57. Sipe DM, Jesurum A, Murphy RF. 1991. Absence of Na+,K( + )-ATPase regulation of endosomal acidification in K562 erythroleukemia cells. Analysis via inhibition of transferrin recycling by low temperatures. J Biol Chem 266:3469-3474.
58. Sognier MA., Zhang Y, Eberle RL, Belli JA. 1992. Characterization of adriamycin-resistant and radiation-sensitive Chinese hamster cell lines. Biochem Pharmacol 44:1859-1868.
59. Sognier MA, Zhang Y, Eberle RL, Sweet KM, Altenberg GA, Belli JA. 1994. Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100). Biochem Pharmacol 48:391-401.
60. Swanson J. 1989. Fluorescent labeling of endocytic compartments. Meth Cell Biol 29:137-151.
61. Thiebaut F, Currier SJ, Whitaker J, Haugland RP, Gottesman MM, Pastan I, Willingham MC. 1990. Activity of the multidrug transporter results in alkalinization of the cytosol: measurement of cytosolic pH by microinjection of a pH-sensitive dye. J Histochem Cytochem 38:685-690.
62. Valverde MA., Diaz M, Sepulveda FV, Gill DR, Hyde SC, Higgins CF. 1992. Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein. Nature 355:830-833.
63. Van Dyke RW. 1986. Anion inhibition of the proton pump in rat liver multivesicular bodies. J Biol Chem 261:15941-15948.
64. van Weert AW, Dunn KW, Gueze HJ, Maxfield FR, Stoorvogel W. 1995. Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J Cell Biol 130:821-834.
65. Wadkins RM, Roepe PD. 1997. Biophysical aspects of P-glycoprotein-mediated multidrug resistance. Int Rev Cytol 171:121-165.
66. Ward DM, Leslie JD, Kaplan J. 1997. Homotypic lysosome fusion in macrophages: analysis using an in vitro assay. J Cell Biol 139:665-673.
67. Warren L, Jardillier JC, Ordentlich P. 1991. Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells. Cancer Res 51:1996-2001.
68. Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM, Pastan I. 1986. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. Cancer Res 46:5941-5946.
69. Yamashiro DJ, Tycko B, Fluss SR, Maxfield FR. 1984. Segregation of transferrin to a mildly acidic (pH 6.5) para-Golgi compartment in the recycling pathway. Cell 37:789-800.
70. Zamora JM, Beck WT. 1986. Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells. Biochem Pharmacol 35:4303-4310.
71. Zen K, Biwersi J, Periasamy N, Verkman AS. 1992. Second messengers regulate endosomal acidification in Swiss 3T3 fibroblasts. J Cell Biol 119:99-110.